Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01220921 · ClinicalTrials.gov registry record · Phase 3

Neurosurgery Patient Outcomes in Treating Spinal Disorders

A Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis, sponsored by Greenwich Hospital.

Completed
Registry status
Phase 3
Development phase
198
Enrollment target
13
Study locations

NCT01220921: Completed Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis, sponsored by Greenwich Hospital.

NCT01220921 is a Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis that has completed, run by Greenwich Hospital. The registered enrollment target is 198 participants. The trial reports 13 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01220921, a Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis, has completed, sponsored by Greenwich Hospital.

COMPLETED
Registry status
Phase 3
Development phase
198 participants
Enrollment target
13
Study locations

Study Summary

The creation of a multi-center cooperative research group encompassing academic and community-based spinal practices . . .

Interventions

  • PROCEDURE Lumbar Discectomy
  • PROCEDURE Single-level lumbar fusion

Study Locations (13)

Connecticut

  • Greenwich Hospital - Greenwich
  • Yale New Haven Hospital - New Haven

California

  • University of California - San Francisco - San Francisco

Maryland

  • Johns Hopkins Hospital - Baltimore

Massachusetts

  • Lahey Clinic - Burlington

New Jersey

  • University of Medicine and Dentistry - New Jersey - Newark

New York

  • Columbia University - Neurological Institute - New York

North Carolina

  • Carolina Spine - Charlotte

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 198 participants
Start Date 2010-09
Est. Completion 2012-09
Phase Phase 3

Sponsor

Greenwich Hospital

3 total trials

What the Registry Record Tells You About NCT01220921

The ClinicalTrials.gov registry entry for NCT01220921 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Greenwich Hospital, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Symptomatic Lumbar Disc Herniation appearing as the primary indexed condition, and to 2 interventions - of which Lumbar Discectomy is the first listed.

NCT01220921 reports 13 study locations spanning 12 distinct geographic areas - top geographies include Connecticut, California, Maryland.

Frequently Asked Questions

What is clinical trial NCT01220921 about?

NCT01220921 is a clinical study titled "Neurosurgery Patient Outcomes in Treating Spinal Disorders". The creation of a multi-center cooperative research group encompassing academic and community-based spinal practices . . .

What is the current status of trial NCT01220921?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 198 participants. The study started on 2010-09. Estimated completion is 2012-09.

What conditions does trial NCT01220921 study?

This clinical trial studies the following conditions: Symptomatic Lumbar Disc Herniation, Symptomatic Grade I Lumbar Spondylolisthesis.

What interventions are being tested in trial NCT01220921?

The interventions under investigation include: Lumbar Discectomy (PROCEDURE), Single-level lumbar fusion (PROCEDURE).

Who is sponsoring clinical trial NCT01220921?

This trial is sponsored by Greenwich Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01220921 being conducted?

This trial has 13 study locations across California, Connecticut, Maryland, Massachusetts, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.